AU2002359524A8 - P2x7 receptor antagonists - Google Patents
P2x7 receptor antagonistsInfo
- Publication number
- AU2002359524A8 AU2002359524A8 AU2002359524A AU2002359524A AU2002359524A8 AU 2002359524 A8 AU2002359524 A8 AU 2002359524A8 AU 2002359524 A AU2002359524 A AU 2002359524A AU 2002359524 A AU2002359524 A AU 2002359524A AU 2002359524 A8 AU2002359524 A8 AU 2002359524A8
- Authority
- AU
- Australia
- Prior art keywords
- receptor antagonists
- antagonists
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33413001P | 2001-11-30 | 2001-11-30 | |
US60/334,130 | 2001-11-30 | ||
PCT/US2002/038126 WO2003047515A2 (en) | 2001-11-30 | 2002-11-27 | P2x7 receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002359524A8 true AU2002359524A8 (en) | 2003-06-17 |
AU2002359524A1 AU2002359524A1 (en) | 2003-06-17 |
Family
ID=23305717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002359524A Abandoned AU2002359524A1 (en) | 2001-11-30 | 2002-11-27 | P2x7 receptor antagonists |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002359524A1 (en) |
WO (1) | WO2003047515A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1617725A (en) * | 2001-12-21 | 2005-05-18 | 王者制药研究发展有限公司 | Tyrosyl derivatives and their use as P2X7 receptor modulators |
CA2625940A1 (en) * | 2005-08-29 | 2007-03-08 | Irma Bernatchez-Lemaire | Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |
PL2105164T3 (en) | 2008-03-25 | 2011-05-31 | Affectis Pharmaceuticals Ag | Novel P2X7R antagonists and their use |
WO2010118921A1 (en) | 2009-04-14 | 2010-10-21 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
CA2792258A1 (en) | 2010-03-05 | 2011-09-09 | President And Fellows Of Harvard College | Induced dendritic cell compositions and uses thereof |
MX2012013075A (en) | 2010-05-14 | 2012-12-17 | Affectis Pharmaceuticals Ag | Novel methods for the preparation of p2x7r antagonists. |
WO2012110190A1 (en) | 2011-02-17 | 2012-08-23 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
WO2012163456A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
WO2012163792A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5245034A (en) * | 1988-12-26 | 1993-09-14 | Kiroyoshi Hidaka | Compound having vessel smooth muscle relaxation activity |
JPH08119922A (en) * | 1994-10-21 | 1996-05-14 | Torii Yakuhin Kk | Orth-pivaloyl-thyrosine derivative |
-
2002
- 2002-11-27 AU AU2002359524A patent/AU2002359524A1/en not_active Abandoned
- 2002-11-27 WO PCT/US2002/038126 patent/WO2003047515A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003047515A3 (en) | 2004-01-08 |
WO2003047515A2 (en) | 2003-06-12 |
AU2002359524A1 (en) | 2003-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL161329A0 (en) | Benzamide and heteroarylamide as p2x7 receptor antagonists | |
AU2003261392A8 (en) | M3muscarinic acetylcholine receptor antagonists | |
IL153308A0 (en) | Thrombin receptor antagonists | |
HK1064100A1 (en) | Adenosine a 2a receptor antagonists | |
EP1351933A4 (en) | Il-8 receptor antagonists | |
IL152775A0 (en) | Il-8 receptor antagonists | |
DZ3309A1 (en) | Il-8 receptor antagonists | |
HK1063791A1 (en) | Nk1 antagonists | |
IL151431A0 (en) | Il-8 receptor antagonists | |
EP1359915A4 (en) | Urotensin-ii receptor antagonists | |
EP1274415A4 (en) | Il-8 receptor antagonists | |
IL151210A0 (en) | Il-8 receptor antagonists | |
AU2002359524A8 (en) | P2x7 receptor antagonists | |
GB0028104D0 (en) | Bombesin receptor antagonists | |
EP1265905A4 (en) | Il-8 receptor antagonists | |
EP1274413A4 (en) | Il-8 receptor antagonists | |
GB0028146D0 (en) | Bombesin receptor antagonists | |
EP1263427A4 (en) | Il-8 receptor antagonists | |
EP1274428A4 (en) | Il-8 receptor antagonists | |
IL156087A0 (en) | Histamine receptor antagonists | |
PL370367A1 (en) | Ccr-3 receptor antagonists v | |
EP1261329A4 (en) | Il-8 receptor antagonists | |
IL158063A0 (en) | Crf receptor antagonists | |
IL151434A0 (en) | Il-8 receptor antagonists | |
GB0125183D0 (en) | Receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |